Citations |
1.Yuan, G. B., Kuang, A. R., Fan, Q., Yu, L. B., and Mi, Y. X. Combined effects of all-trans-retinoic acid and trichostatin A on the induction of differentiation of thyroid carcinoma cells K1. Chin J Cancer, 29: 379-384. 2.Liu, D., Hou, P., Liu, Z., Wu, G., and Xing, M. Genetic alterations in the phosphoinositide 3-kinase/Akt signaling pathway confer sensitivity of thyroid cancer K1 cells to therapeutic targeting of Akt and mammalian target of rapamycin. Cancer Res, 69: 7311-7319, 2009. 3.Hibma, M. H., Real, N. C., Wiles, A., Dobson-Le, D., Dix, B. R., Wynford-Thomas, D., Braithwaite, A. W., and Royds, J. A. Increased apoptosis and reduced replication efficiency of the E3 region-modified dl309 adenovirus in K1 cancer cells. Virus Res, 145: 112-120, 2009. 4.Schweppe, R. E., Kerege, A. A., Sharma, V., Poczobutt, J. M., Gutierrez-Hartmann, A., Grzywa, R. L., and Haugen, B. R. Distinct genetic alterations in the mitogen-activated protein kinase pathway dictate sensitivity of thyroid K1 cancer cells to mitogen-activated protein kinase kinase 1/2 inhibition. Thyroid, 19: 825-835, 2009. 5.Desailloud, R., Sane, F., Caloone, D., and Hober, D. Persistent infection of a carcinoma thyroid K1 cell line with coxsackievirus B. Thyroid, 19: 369-374, 2009. 6.Lavra, L., Ulivieri, A., Rinaldo, C., Dominici, R., Volante, M., Luciani, E., Bartolazzi, A., Frasca, F., Soddu, S., and Sciacchitano, S. Gal-3 is stimulated by gain-of-function p53 mutations and modulates chemoresistance in anaplastic K1 thyroid carcinomas. J Pathol, 218: 66-75, 2009. |